Digital health company DarioHealth (NSDQ:DRIO) said today that it closed a $5 million private placement with new and existing investors for shares of the company’s common stock and shares of the company’s Series B convertible preferred stock.
The Israel-based company said current shareholders accounted for 58% of the securities sold in the offerings.
Get the full story at our sister site, Drug Delivery Business News.
The post Diabetes app developer DarioHealth closes $5m private placements appeared first on MassDevice.
from MassDevice http://ift.tt/2wyfK64
Cap comentari:
Publica un comentari a l'entrada